UNICEF: 190 million COVID-19 vaccines delivered under COVAX

On the anniversary of UNICEF’s first delivery to country, Bangladesh is the number one recipient of COVID-19 vaccines under COVAX

31 May 2022
UN0482644
UNICEF/UN0482644/Sujan (File Photo)

DHAKA, 31 May 2022 – In one year, UNICEF has delivered over 190 million doses of COVID-19 vaccines to Bangladesh through COVAX. To date, Bangladesh remains the top recipient of doses under COVAX, the global initiative co-led by the Coalition for Epidemic Preparedness Innovation, Gavi, the Vaccine Alliance, and the World Health Organization, with UNICEF as a key delivery partner. COVAX accounts for more than 62 per cent of doses received by the country. The goal of COVAX is to ensure equitable access of COVID-19 vaccines globally.

COVID-19 vaccinations started in Bangladesh in February 2021. UNICEF delivered the first COVAX shipment of vaccines to Bangladesh on 1 June 2021, at a time when only 4 per cent of the population in the country were fully vaccinated. A year on, thanks to a strong partnership between the Government, the World Health Organization, UNICEF and other partners, Bangladesh has fully vaccinated with two doses 69 per cent of its population – a staggering 117 million people.

“With the committed strong leadership of the Honourable Prime Minister, Bangladesh has shown incredible resilience to face the COVID-19 pandemic. With continuous supply of vaccines and hard work of dedicated health workers, we have been able to vaccinate the targeted population without wasting doses,” said Prof. Dr. Meerjady Sabrina Flora, Additional Directorate General (Planning and Development), DGHS, Ministry of Health and Family Welfare.

UNICEF has also supported the Government’s COVID-19 response by strengthening the cold chain and ultra-cold chain, delivering critical supplies, generating demand, supporting data management and building capacity for vaccine administration. These investments will continue to serve the people of Bangladesh for years to come beyond the COVID-19 crisis. They are especially important to keep children safe from vaccine-preventable diseases such as measles and polio.

“Bangladesh’s ability to absorb and roll out COVID-19 vaccines is a testament to what can be achieved when there is political commitment and an equitable supply of vaccines. The success in getting millions of vaccines quickly and safely into arms in every corner of the country has been nothing short of remarkable,” said Mr. Sheldon Yett, UNICEF Representative to Bangladesh.

A COVID-19 booster dose campaign is planned for June.

“Bangladesh with 69 per cent fully vaccinated population is close to achieving the global benchmark of 70 per cent fully vaccinated population by June 2022. The success could not have been possible without COVAX support. The ongoing pace of vaccination gives us a hope to see the end of COVID-19 as a global health emergency. Let us also not forget that the pandemic is not over anywhere until it’s over everywhere” said Dr. Bardan Jung Rana, WHO Representative to Bangladesh”

#####

Media contacts

Faria Selim
Communication Specialist
UNICEF Bangladesh
Tel: +8809604107077
Moyukh Mahtab
UNICEF Bangladesh
Tel: +8801685023541

About UNICEF

UNICEF works in some of the world’s toughest places, to reach the world’s most disadvantaged children. Across more than 190 countries and territories, we work for every child, everywhere, to build a better world for everyone. 

UNICEF’s Regional Office for South Asia (ROSA) works with UNICEF Country Offices in Afghanistan, Bangladesh, Bhutan, India, the Maldives, Nepal, Pakistan and Sri Lanka to help to save children’s lives, defend their rights, and help them fulfil their potential. For more information about UNICEF’s work for children in South Asia, visit www.unicef.org/rosa and follow UNICEF ROSA on Twitter and Facebook.

For more information about COVID-19, click here.

 

About COVAX

COVAX is the vaccines pillar of the ACT-Accelerator. It is co-led by the Coalition for Epidemic Preparedness Innovation (CEPI), Gavi, the Vaccine Alliance, and the World Health Organization (WHO) – working in partnership with developed and developing country vaccine manufacturers, UNICEF, the World Bank, Civil Society Organizations and others. COVAX is the only global initiative that is working with governments and manufacturers to ensure COVID-19 vaccines are rapidly available worldwide to economies of all financial means.